NASDAQ · Biotechnology

Caribou Biosciences Inc (CRBU)

$0.28 -8.44%
22 Oversold Daily RSI (14) · 19 Nov 2026

Moving averages

SMA 200$1.59-82.12%

Company profile

Caribou Biosciences Inc. is a pioneering biotechnology firm specializing in genome editing through its proprietary CRISPR technology, aimed at developing transformative therapies for genetic disorders and oncology. With a robust and diversified pipeline addressing significant unmet medical needs, the company is well-positioned to lead advancements in precision medicine. Caribou's strategic collaborations and unwavering commitment to research excellence underpin its mission to revolutionize treatment paradigms and improve patient outcomes, establishing its foothold as a key player in the biopharmaceutical sector.

SectorHealthcare
IndustryBiotechnology
Market cap$42.21M
P/E ratioNone
EPS$-1.03
Beta2.488
Dividend yield0.00%
52-week high$2.49
52-week low$0.37

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for CRBU

An email when CRBU closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 5:37 AM EST